Atlas Trials

Rilonacept (Arcalyst ®) in the Treatment of Subacromial Bursitis

Clinical trial NCT01830699 · COMPLETED

Trial details

NCT number
NCT01830699
Sponsor
Keesler Air Force Base Medical Center
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Subacromial Bursitis
Start date
2013-03-01
Primary completion
2014-03-01
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.